(Q33732102)

English

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Leishmania infantum

1 reference

based on heuristic

inferred from title

author name string

Maria Agallou

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Evita Athanasiou

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Olga Koutsoni

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Eleni Dotsika

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Evdokia Karagouni

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

10 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Frontiers in Immunology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

268

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

How good is automated protein docking?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmaniasis: current status of available drugs and new potential drug targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

CD8(+) T cells in leishmania infections: friends or foes?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmaniasis: vaccine candidates and perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmaniasis: prevention, parasite detection and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Visceral leishmaniasis: immunology and prospects for a vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Human leukocyte antigen-A, -B, -C, -DRB1 allele and haplotype frequencies in Americans originating from southern Europe: contrasting patterns of population differentiation between Italian and Spanish Americans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmaniasis Vaccine: Where are We Today?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmaniasis emergence in Europe.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Computational analysis of cysteine proteases (Clan CA, Family Cl) of Leishmania major to find potential epitopic regions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Definition of MHC supertypes through clustering of MHC peptide-binding repertoires

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Harnessing bioinformatics to discover new vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

A systematic bioinformatics approach for selection of epitope-based vaccine targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmaniasis vaccine candidates for development: a global overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Developing an epitope-driven tuberculosis (TB) vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

ClusPro: a fully automated algorithm for protein-protein docking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Immunity and immunosuppression in experimental visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Parasitic adaptive mechanisms in infection by leishmania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

M-1/M-2 macrophages and the Th1/Th2 paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Evolutionarily conserved proteins as prominent immunogens during Leishmania infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Organ-specific immune responses associated with infectious disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Histone H1 expression varies during the Leishmania major life cycle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Lymphokine enhances oxygen-independent activity against intracellular pathogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051127

21 June 2018

Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Modeling the adaptive immune system: predictions and simulations

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Histone genes in trypanosomatids.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Identification of Leishmania major cysteine proteinases as targets of the immune response in humans

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

PIPER: an FFT-based protein docking program with pairwise potentials.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

ClusPro: an automated docking and discrimination method for the prediction of protein complexes

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Humoral and Cellular Immune Responses to Synthetic Peptides of the Leishmania donovani Kinetoplastid Membrane Protein-11

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

DEAD-box proteins, like Leishmania eIF4A, modulate interleukin (IL)-12, IL-10 and tumour necrosis factor-alpha production by human monocytes.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Leishmania infantum LeIF and its recombinant polypeptides modulate interleukin IL-12p70, IL-10 and tumour necrosis factor-α production by human monocytes

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Identification of Th1 epitopes within molecules from the lung-stage schistosomulum of Schistosoma japonicum by combining prediction analysis of the transcriptome with experimental validation

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

Evaluation of IFN-gamma production by CD8+ T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.3389%2FFIMMU.2014.00268

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetoplastid membrane protein-11 is present in promastigotes and amastigotes of Leishmania amazonensis and its surface expression increases during metacyclogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of skewed Th1/Th2 T-cell differentiation via subcutaneous immunization with Freund's adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24959167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FIMMU.2014.00268

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33732102&oldid=1617873038"